9 completed. 9 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 9 | Completed 9 |
Follow Candidiasis, Invasive: new trials by email Literature Review of Candidiasis, Invasive trials Research Report on Candidiasis, Invasive
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluate Bioequivalence of Micafungin (50mg/Vial) Micafungin - Invasive Candidiasis | Phase 4 | Completed | Yung Shin Pharm. Ind. Co., Ltd. | 14 | 2022-01-06 | 2022-08-11 |
| Pharmacokinetics of Micafungin in Patients of Intensive Care Units micafungin - Invasive Candidiasis | Phase 4 | Completed | University Hospital, Limoges | 60 | 2014-06-01 | 2025-11-21 |
| Negative Beta Glucan in ICU Patients Anidulafungin - Candidemia | Phase 4 | Completed | Universidade Federal do Rio de Janeiro | 85 | 2012-11-01 | 2019-07-08 |
| Comparison of Candida Eradication and Serum Cidal Activity of Echinocandins micafungin, Micafungin, Caspofungin - Candidemia | Phase 4 | Completed | Gary E. Stein, Pharm.D. | 21 | 2008-12-01 | 2024-04-30 |
| A Study To Assess The Anidulafungin And Voriconazole Concentration In Lung Following Intravenous Administration In Healthy Subjects anidulafungin and voriconazole - Aspergillosis, Candidemia | Phase 4 | Completed | Pfizer | 24 | 2008-09-01 | 2010-02-09 |
| This Is An Open-Label, Non-Comparative Study Designed To Evaluate A Short Course Of IV Anidulafungin, Followed Optionally By Oral Voriconazole, For The Treatment Of Candidemia And Invasive Candidiasis Anidulafungin, Voriconazole - Candidemia, Invasive Candidiasis | Phase 4 | Completed | Pfizer | 54 | 2008-02-01 | 2011-01-17 |
| Randomized Study of Caspofungin Prophylaxis Followed by Pre-emptive Therapy for Invasive Candidiasis in the Intensive Care Unit (ICU) Caspofungin, Normal Saline - Invasive Candidiasis | Phase 4 | Completed | Mycoses Study Group | 222 | 2007-08-01 | 2011-05-09 |
| Study Will Evaluate The Safety And Efficacy Of Anidulafungin In Patients With Candidemia Or Invasive Candidiasis Eraxis (anidulafungin), Diflucan (fluconazole), Vfend (voriconazole) - Candidiasis | Phase 4 | Completed | Pfizer | 282 | 2007-07-01 | 2011-10-03 |
| CRITIC - Treatment of Candidemia and Invasive Candidiasis AmBisome - Candidemia, Invasive Candidiasis | Phase 4 | Completed | Gilead Sciences | 39 | 2007-05-01 | 2009-03-27 |
Candidemia (6) · Aspergillosis (1) · Candidiasis (1) · Mycoses (1) · Torulopsis (1)
Bacterial Infections and Mycoses (9) · Infections (9) · Invasive Fungal Infections (9) · Candidiasis (8) · Mycoses (8) · Fungemia (6) · Inflammation (6) · Pathologic Processes (6) · Pathological Conditions, Signs and Symptoms (6) · Sepsis (6) · Systemic Inflammatory Response Syndrome (6)
Anidulafungin (4) · Micafungin (3) · Voriconazole (3) · Caspofungin (2) · Fluconazole (1) · Saline Solution (1) · liposomal amphotericin B (1)
Pfizer (3) · Gary E. Stein, Pharm.D. (1) · Gilead Sciences (1) · Mycoses Study Group (1) · Universidade Federal do Rio de Janeiro (1) · University Hospital, Limoges (1) · Yung Shin Pharm. Ind. Co., Ltd. (1)
United States (4) · Brazil (2) · Chile (1) · Colombia (1) · France (1) · Italy (1) · Mexico (1) · Panama (1) · South Korea (1) · Taiwan (1)
Gary E Stein, Pharm.D. (1) · Luigi Picaro (1) · Luis Ostrosky-Zeichner, MD (1) · Marcio Nucci, MD (1) · Peter G Pappas, MD (1)
PMID 28459966, PMID 28597967, PMID 31280481, PMID 33891293, PMID 23710653, PMID 24550378, PMID 24559321, PMID 27287231, PMID 41219680